Provivi

Santa Monica, CA · Founded 2013 · Privately Held (backing)

Developer of insect pheromones designed to protect food supplies without toxic residues. Provivi is based in Santa Monica, CA and was founded in 2013. Its last reported valuation was $420 million in Mar 2021. It has raised $248 million across 6 recorded rounds; the latest was a $25.5 million early-stage round in Sep 2025.

Last reported valuation
$420.0M
Oct 2026
Priced at
—
Total raised
$248.1M
Last round
Early Stage VC
Sep 2025
What is Provivi worth?
$420.0Mlast reported valuation · Oct 2026

Provivi's last reported valuation, Mar 2021. Nothing priced has surfaced since.

Free account
More of Provivi with a free account
  • ·The complete investor list: 13 names
  • ·Watch Provivi: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Provivi funding history

6 rounds
DateRoundRaisedPost-money
Sep 2025Early Stage VC$25.5M▮
Jun 2019Later Stage VC$85.0M▮
Jul 2017Early Stage VC$36.5M▮
Jun 2015Early Stage VC$7.5M▮
Jun 2014Debt$1.0M▮
Jun 2013Seed Round$1.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Provivi valuation

Provivi's last reported valuation was $420 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Provivi raised?

Provivi has raised $248 million across 6 recorded rounds since 2013. The largest was an $85 million later-stage round in Jun 2019; the most recent was a $25.5 million early-stage round in Sep 2025.

Provivi has filed 10 Form Ds with the SEC since 2015, most recently in Oct 2019 ($85 million sold to 21 investors).

Institutional holders and vehicles

In the last 12 months, 2 investment vehicles were formed to buy Provivi shares, reporting $4.7 million sold to 54 investors, per SEC Form D filings (most recent Mar 2026).

How Provivi's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Provivi, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Provivi

What is Provivi worth?
Provivi is valued at $420.0M as of Oct 2026. Provivi's last reported valuation, Mar 2021. Nothing priced has surfaced since.
How much has Provivi raised?
Provivi has raised $248.1M in total funding across 6 recorded rounds.
When did Provivi last raise?
Provivi last raised in Sep 2025 (Early Stage VC), raising $25.5M.